In this research, we found that KLF6 expresses lowly in pancreatic cancer samples and that survival analysis demonstrates that lower KLF6 expression is linked to a worse survival prognosis in PAAD. This evidence concerns the gene KLF6 and familial pancreatic carcinoma.